| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
MUNICH—GPC Biotech AG announced it will close its Waltham, Mass.-based discovery facilities, consolidating the U.S. discovery programs with its Munich-based efforts. The move will see the company reduce its total workforce by 16%. According to company CEO Bernd Seizinger, the move was prompted by GPC's acquisition of Axxima Pharmaceuticals in 2005 and the ending this year of a collaboration with Waltham's ALTANA Pharma.
 
"While we believe this action makes sense for the company strategically, it was not a decision we made lightly as it has necessitated the closing of our Waltham site," he says.
 
The company has by no means given up on the United States, however, as it expects to continue to build its clinical development and commercialization groups at its Princeton, N.J.-based operations. Part of that process, Seizinger suggests, will be the hiring of a U.S. field sales force.

About the Author

Related Topics

Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue